Free-text search
Articles per year:
Content Types
-
GSK to close German vaccine plant – 641 jobs at risk
Demand for traditional flu vaccines is declining. GSK is now consolidating production in Canada and closing its plant in Dresden, putting 641 jobs at risk.
-
Tandem Health raises $100m to expand in Europe
Swedish AI company Tandem Health has raised $100m. The funding will be used to strengthen the company’s position in Europe.
-
Etcamah misses main goal after recent FDA approval
AstraZeneca’s tablet therapy Etcamah for breast cancer has failed to meet the primary endpoint in a Phase III study, the company reports. The announcement comes just a week after the drug received approval in the United States for another form of breast cancer.
-
Danish pharma giant shortens name – becomes Novo
A shorter name, a new corporate culture and a faster pace. Novo Nordisk is overhauling its brand as the pharmaceutical giant seeks to move faster and sharpen its competitive edge.
-
More details emerge about QuantumCell’s operational team
Jesper Bastlund has joined biotech start-up QuantumCell as Vice President of Biology and Translational Science, according to a post on LinkedIn.
-
Two nordic paths to fewer RSV admissions
Antibodies and vaccines are having major impact on infant hospitalizations.
-
Alzinova strengthens its cash position ahead of Phase II study
The Swedish research company Alzinova has initiated the start‑up phase of its Phase II study in Alzheimer’s disease – and is simultaneously announcing a rights issue of up to SEK 51 million to help finance the study.
-
US boost for Lundbeck’s Cushing’s drug candidate
Lundbeck has received orphan drug designation from the US FDA for asedebart, Lu AG13909, for the treatment of endogenous Cushing’s syndrome.
-
Sectra scales up in Denmark’s new eastern region
When Region Hovedstaden and Region Sjælland merge to form Region Østdanmark, Sectra’s medical imaging service Sectra One will be expanded to all hospitals in the region.
-
Getinge aims to expand in transplantation – with an eye on China
The Swedish medtech company Getinge plans to expand within organ transplantation in Europe and Asia, says CEO Mattias Perjos.
-
CordenPharma targets 500m injectable units with €80m expansion
CordenPharma is investing €80m to significantly expand its manufacturing capacity for sterile injectable medicines in Italy. Once completed, the site will be able to handle up to 500 million injectable units a year.
-
Marie Gårdmark: Are FDA and EMA drifting apart?
Are FDA and EMA beginning to drift apart on what it takes to approve new medicines? And what could that mean for drug development on both sides of the Atlantic? Marie Gårdmark explores the question in a column.
-
How SweTrial aims to bring more clinical trials to Sweden
Sweden has lost ground in clinical trials. SweTrial now aims to reverse the trend, but both the Swedish Medical Products Agency and the pharmaceutical industry point to the same bottleneck: capacity within the healthcare system.
-
Artisan Partners demands board changes at Novartis after share-price plunge
Artisan Partners, one of Novartis’ 20 largest shareholders, is demanding changes to the pharmaceutical company’s board and tighter oversight of acquisitions after two setbacks in clinical trials. Reuters reports this.
-
Breakthroughs in narcolepsy recognized by Lasker Awards
This year’s Lasker Awards are presented to researchers behind discoveries that have led to breakthroughs in narcolepsy and hemophilia – and to one of Hollywood’s most prominent patient activists.
-
Novonesis to invest €600 million in India factory
Danish biosolutions manufacturer Novonesis has decided to invest massively in its Indian factory.
-
Sobi gains regulatory momentum with new FDA Fast Track designation
Sobi has secured a US FDA Fast Track designation for pacritinib, advancing the drug’s development as a potential treatment for the rare and severe autoinflammatory disorder VEXAS syndrome.
-
AddLife adds new company to its portfolio
The Swedish life science group AddLife has acquired Unicam Sistemas Analíticos, a Portuguese distributor of advanced analytical laboratory equipment.
-
Denmark a leader in EU clinical trials: “We should never accept unnecessary delays”
A principal of quick processing as well as engaging in ongoing dialogue with sponsors has helped Denmark to lead EU in clinical trials.
-
Elizabeth Schepke named Childhood cancer researcher of the Year 2026
Oncologist Elizabeth Schepke has been named Childhood Cancer Researcher of the Year 2026 by the Swedish Childhood Cancer Foundation.
-
Bangladesh was close to eliminating measles – now it has the world’s largest outbreak
Bangladesh was close to eliminating measles. Now the country is battling the world’s largest outbreak, with more than 166,000 suspected cases and nearly 1,000 reported measles-related deaths since the spring.
-
SmartCella secures key patents in the US and Japan
Swedish drug-delivery company SmartCella has secured the main patent for its Extroducer device in the US and Japan, completing global protection following the European approval granted in 2024.
-
Regulatory milestone strengthens Xinnate’s EB program
Xinnate has received a notification from the U.S. Food and Drug Administration (FDA) that may bring significant advantages in the development of the company’s treatment for the skin disease Epidermolysis Bullosa (EB).
-
Nordic newcomer on an acquisition drive – snaps up four Swedish distributors
Over the past five years, Medu Group has built a Nordic distribution business. “We aim to become one of the major Nordic distributors in medtech,” says Magnus Schüldt, CEO of Medu Sverige.
BREAKING